Journal
JOURNAL OF IMMUNOLOGY
Volume 196, Issue 10, Pages 4274-4290Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1500455
Keywords
-
Categories
Funding
- Ministerio de Economia y Competitividad (Madrid, Spain) through ISCIII [PI10/1073, PI13/01490]
- FEDER funds/European Regional Development Fund (ERDF)
- La Marato de TV3 Foundation [12/1210]
- Generalitat de Catalunya [2014SGR541, 2014SGR804]
- Researchers Consolidation Program from the Sistema Nacional de Salut-Departament de Salut Generalitat de Catalunya [CES06/012]
- Ministerio de Economia y Competitividad [SAF2011-26583]
- Ciber de Enfermedades Raras
- Fundacion Renal Inigo Alvarez de Toledo
- Swedish Research Council [K2009-68X-14928-06-3]
- Swedish Cancer Foundation
Ask authors/readers for more resources
The activation of the complement system is a key initiating step in the protective innate immune-inflammatory response against injury, although it may also cause harm if left unchecked. The structurally related soluble complement inhibitors C4b-binding protein (C4BP) and factor H (FH) exert a tight regulation of the classical/lectin and alternative pathways of complement activation, respectively, attenuating the activity of the C3/C5 convertases and, consequently, avoiding serious damage to host tissues. We recently reported that the acute-phase C4BP isoform C4BP lacking the beta-chain plays a pivotal role in the modulation of the adaptive immune responses. In this study, we demonstrate that FH acts in the early stages of monocyte to dendritic cell (DC) differentiation and is able to promote a distinctive tolerogenic and anti-inflammatory profile on monocyte-derived DCs (MoDCs) challenged by a proinflammatory stimulus. Accordingly, FH-treated and LPS-matured MoDCs are characterized by altered cytoarchitecture, resembling immature MoDCs, lower expression of the maturation marker CD83 and the costimulatory molecules CD40, CD80, and CD86, decreased production of key proinflammatory Th1-cytokines (IL-12, TNF-alpha, IFN-gamma, IL-6, and IL-8), and preferential production of immunomodulatory mediators (IL-10 and TGF-beta). Moreover, FH-treated MoDCs show low Ag uptake and, when challenged with LPS, display reduced CCR7 expression and chemotactic migration, impaired CD4(+) T cell alloproliferation, inhibition of IFN-gamma secretion by the allostimulated T cells, and, conversely, induction of CD4(+)CD127(low/negative)CD25(high)Foxp3(+) regulatory T cells. Thus, this novel noncanonical role of FH as an immunological brake able to directly affect the function of MoDCs in an inflammatory environment may exhibit therapeutic potential in hypersensitivity, transplantation, and autoimmunity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available